Article Information
History
- October 18, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Marton König, MD, PhD1,†,
- Hilde Marie Torgauten, MD2,3,
- Mathias Herstad Øverås, MD1,
- Adity Chopra, PhD4,
- Åslaug Rudjord Lorentzen, MD, PhD5,6,
- The Trung Tran, PhD4,
- Siri Mjaaland, MD, PhD7,
- Ingeborg Sundsvalen Aaberge, MD, PhD7,
- Kjell-Morten Myhr, MD, PhD2,3,
- Stig Wergeland, MD, PhD2,8,
- Tone Berge, MD, PhD9,10,
- Hanne Flinstad Harbo, MD, PhD1,11,
- Øivind Fredvik Torkildsen, MD, PhD2,3,
- Trygve Holmøy, MD, PhD11,12,
- Elisabeth Gulowsen Celius, MD, PhD1,11,
- Ludvig Andre Munthe, MD, PhD4,13,
- John Torgils Vaage, MD, PhD4,
- Fridtjof Lund-Johansen, MD, PhD*,4 and
- Gro Owren Nygaard, MD, PhD*,1
- 1Oslo University Hospital, Department of Neurology, Oslo, Norway
- 2Neuro-SysMed, Department of Neurology, Haukeland University Hospital
- 3University of Bergen, Department of Clinical Medicine
- 4Oslo University Hospital, Department of Immunology, Oslo, Norway
- 5Sørlandet Hospital, Department of Neurology, Kristiansand, Norway
- 6Sørlandet Hospital, The Norwegian National Advisory Unit on Tick-borne diseases, Arendal, Norway
- 7Norwegian Institute of Public Health, Division of Infection Control, Oslo, Norway
- 8Norwegian MS Registry and Biobank, Haukeland University Hospital, Bergen, Norway
- 9Oslo Metropolitan University, Department of Mechanical, Electronic and Chemical Engineering, Oslo, Norway
- 10Oslo University Hospital, Department of Research, Innovation and Education, Division of Clinical Neuroscience, Oslo, Norway
- 11University of Oslo, Institute of Clinical Medicine, Oslo, Norway
- 12Akershus University Hospital, Department of Neurology, Oslo, Norway
- 13University of Oslo, KG Jebsen Centre for B cell malignancy, Oslo, Norway
- ↵†Corresponding author:
Marton König, MD, PhD, Department of Neurology, Oslo University Hospital, PB 4956 Nydalen, N-0424 Oslo, Norway, phone: +47 454 17 748, e-mail: makoni{at}ous-hf.no
Posted October 18, 2021.
Efficacy and safety of a third SARS-CoV-2 vaccination in multiple sclerosis vaccine non-responders
